The enteral feeding formulas market is expected to grow from US$ 7,803.45 million in 2021 to US$ 11,726.37 million by 2028 at a CAGR of 6.0% between 2022 and 2028.
Crohn’s disease, gastrointestinal disease due to trauma, bowel obstruction (BO), microscopic colitis, short bowel syndrome, and ulcerative colitis are a few gastrointestinal diseases. According to the article in Heathline, in 2021, around 40% of people across the world were affected by functional gastrointestinal disorder. According to Medscape, in developed countries, the most common cause of small-bowel obstruction (SBO) is intra-abdominal adhesions, accounting for ~65 to 75% of cases, followed by hernias. In contrast, in developing countries, SBO is primarily caused by hernias (30–40%), adhesions (about 30%), and tuberculosis (about 10%). According to the article published by World Journal of Emergency Surgery, bowel obstruction is an important cause of morbidity and mortality accounting for nearly 30,000 deaths and more than US$3 billion per year in direct medical costs. Bowel obstruction is responsible for ~15% of hospital admissions for acute abdominal pain in the US, and ~ 20% of cases need acute surgical care.
Crohn’s disease is a complex, long-lasting (chronic) disorder that primarily affects the digestive system. It is most common disease in North America and Western Europe and has a prevalence of 100 to 300 per 100,000 in these regions. According to Medline Plus, more than half a million in North American and Western European people are currently suffering from Crohn’s disease. Patients suffering from gastrointestinal disease are at an increased risk of nutritional deterioration due to fasting for the diagnostic tests, therapeutic dietary restriction, and appetite loss due to anorexia or altered nutritional requirement. Gastrointestinal disease patients cannot consume food orally. Therefore, enteral route is preferred to provide the required nutrients. A few brands that caters to gastroenterology disorders are Ensure, Ensure HN, Ensure Powder, Isocal, Lonalac Powder, Meritene, Meritene Powder, Osmolite, Osmolite HN, Portagen Powder, Sustacal, Sustagen Powder, and Travasorb. Therefore, the growing prevalence of gastrointestinal diseases drives the growth of the enteral feeding formulas market.
The growth of the enteral feeding formulas market is majorly attributed to the rising prevalence of gastrointestinal disorders and the increasing prevalence of cachexia. However, mechanical or enteral tube-related problems hamper the growth of the market. The usage of next-generation technology for proper enteral nutrition feeding is projected to offer lucrative opportunities for the growth of the enteral feeding formulas market during the forecast period.
The "Global Enteral Feeding Formulas Market Analysis to 2028" report aims to provide an overview of enteral feeding formulas market with detailed market segmentation based on type, application, form, age group, and distribution channel. The report provides key statistics based on the financial performances of the leading enteral feeding formulas market players. It also offers key trends and opportunities in the market.
The global enteral feeding formulas market is segmented on the basis of type, application, form, age group, and distribution channel. Based on type, the market is segmented into standard formulas, peptide formulas, specialized formulas, and others. By application, the market is segmented into respiratory disorders, cancer, gastroenterology disorders, diabetes, liver/kidney disease, neurology, post COVID-19, and others. Based on form, the enteral feeding formulas market is segmented into powder, liquid, and semi-solid. Based on age group, the market is bifurcated into adult (18+ years) and children (till 18 years). In terms of distribution channel, the market is segmented into hospital pharmacies, retail stores, and others.
The global enteral feeding formulas market is segmented into five major regions—North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report covers analysis and forecast of 18 countries globally along with trends and opportunities prevailing in the regions.
North America dominated the enteral feeding formulas market capturing more than 41% market share in 2021. The market growth in North America is driven by the growing prevalence of gastroenterology disorders in the US. According to Centers for Disease Control and prevention, the number of adults with diagnosed ulcers in the United States was 14.8 million in 2020. The number of visits to emergency departments with diseases of the digestive system as the primary diagnosis was 7.9 million in 2020 in the United States. As a result, the enteral feeding formulas acts as a medium to overcome or prevent such illnesses owing to the source of nutrients (protein, carbohydrates, etc.) received from the enteral feeding formula products.
The below figure shows the revenue growth trend in the enteral feeding formulas market:
Source: The Insight Partners Analysis
The report analyzes factors, such as drivers, restraints, opportunities, and future trends, which impact the growth of the enteral feeding formulas market. It also provides exhaustive Porter's five forces analysis of the factors influencing the market.
IMPACT OF COVID-19 PANDEMIC
According to a research article published in Critical Care, 2020, the novel coronavirus may invade the gastrointestinal tract, neurological systems, and kidneys, which may adversely affect the nutrition delivery among COVID-19 patients. As per the guidelines by the European Society for Clinical Nutrition and Metabolism (ESPEN) on nutrition in the ICU, gastric/renal enteral formulas are recommended for severe COVID-19 patients admitted in the intensive care units (ICUs). Hence, the demand for enteral feeding formulas increased globally due to the rising number of COVID-19 patients, especially in ICUs.
The report covers key developments in the enteral feeding formulas market. Various companies are focusing on organic growth strategies, such as product launches, product approvals, and patents and events. In addition, acquisitions, and partnership & collaborations are among the inorganic growth strategies witnessed in the market. These activities have paved way for the expansion of business and customer base of market players. The players operating in the enteral feeding formulas market are anticipated to experience lucrative growth opportunities in the future owing to the rising demand for enteral feeding formulas.
The report also includes the profiles of key enteral feeding formulas market companies along with their SWOT analysis and market strategies. In addition, it focuses on leading industry players with information, such as company profiles, components and services offered, financial information of last 3 years, and key development in past five years.
Below mentioned is the list of a few companies engaged in the enteral feeding formulas market.
- Nestle Health Science
- Magnacal Renal
- Kate Farms
- Smartfish AS
- Fresenius Kabi AG
- Hormel Foods Corporation
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Type, Application, Form, Age Group, Distribution Channel, and Geography
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
The List of Companies
2. B. Braun Melsungen AG
4. Fresenius Kabi India Pvt. Ltd
5. Global Health Products, Inc.
6. Mead Johnson and Company, LLC
7. Meiji Holdings Co., Ltd.
9. Hormel Foods Corporation
10. Victus, Inc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Drug Delivery Market
Forecast to 2028 - Global Analysis By Route of Administration (Injectable Drug Delivery, Oral Drug Delivery, Transmucosal Drug Delivery, Topical Drug Delivery, Implantable Drug Delivery, and Ocular Drug Delivery), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and End User (Hospitals and Clinics, Home Care Settings, and Other End User)
Enteral and Parenteral Medical Nutrition Market
Forecast to 2028 - Global Analysis by Indication [Elderly, Gastrointestinal Disorders (IBD, IBS, and Others), Diabetes, Cancer, Respiratory Disorders, Alzheimer's Disease, Dementia, Renal Disease, Liver Failure, Post COVID-19, and Other Indications], Nutrition Type (Supplemental and Sole–Source), Form (Liquid, Powder, and Semi–Solid), Product Type (General and Disease–Specific), Route of Administration (Oral, Tube Feed, and Parenteral), Age Group (Above 60 Years, 18–60 Years, 3–18 Years, and Below 3 Years), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
CIN & HR-HPV Treatment Market
Forecast to 2028 - Global Analysis By Disease Type (Cervical Intraepithelial Neoplasia 1, Cervical Intraepithelial Neoplasia 2, and Cervical Intraepithelial Neoplasia 3), Strain Type (HPV 16, HPV 18, and Others), Offering (Diagnostic Method and Treatment), Product Type (Kits & Reagents, Instruments, and Services), and End User (Hospitals & Clinics, Diagnostic Laboratories, Specialized Clinical Laboratories, and Others)
Pharmaceutical Fluid Handling Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Offering (Equipment & Solutions and Services), Tubing (Thermoplastic Elastomers, Polyvinyl Chloride, and Silicone), Application (Fluid Handling & Management, Fluid Preparation, Integration & Automation, Buffer Management, and Others), Usage (Cough Syrup, Intravenous Product, Complex Active Pharmaceutical Ingredients, and Others), and End User (Biotechnology Companies, Pharmaceutical & Medical Companies, and Others)
Enteral Medical Nutrition Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Indication (Respiratory Disorders, Cancer, Post COVID-19, Gastrointestinal Disorders, Liver Failure, and Others), Nutrition Type (Supplemental and Sole-Source), Form (Powder, Liquid, and Semi-Solid), Product (Standard Protein Diet, High Protein Diet, Fruit Juice Based Oral Nutritional Supplement, and Others), Distribution Channel (Hospital Pharmacies, Retail Stores, and Others), and Age Group [Child (Till 18 Years) and Adults (18+years)]
Glycomic Therapeutics Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Class (Isolated and Synthetic), Structures [Glycoproteins, Targeting Sialic Acid, Proteoglycans, Targeting Glycosaminoglycans, Glycosylphosphatidylinositol (GPI)-Anchored Proteins & Heparin Based Glycans, Targeting Glycosphingolipids, and Others], Indications (Thrombosis & Chemoprophylaxis, Anaemia, Anti-Adhesive & Anti-Inflammatory, Cataracts, Gaucher’s Disease, MPS-1 & IV, Cancer, Alzheimer’s Disease, Influenza Type A & B, and Others), and Mode of Action [Inhibits Neuraminidase; Inhibits Heparanase and Selectins and Blocks Interactions Between Growth Factors and Heparan Sulfate; Erythropoietin & Enzyme Replacement Therapy (ERT); Tissue Plasminogen Activator; Inhibits Glucosylceramide Synthase; Interleukin 1, 2 & 3; Beta & Gamma Interferons; and Others]